MétaCan
Menu
Back to cohort
Record W2114193357 · doi:10.3121/cmr.8.1.41-a

PS1-06: Increased Incident Renal Disease with ACE-1 + Thiazide Therapy for Hypertension: The Geisinger Clinic Population

2010· article· en· W2114193357 on OpenAlexaff
Robert D. Langer, Jove Graham, Sean Hennessy, Raymond R. Townsend, V. Weber, Fred Bloom

Bibliographic record

VenueClinical Medicine & Research · 2010
Typearticle
Languageen
FieldMedicine
TopicDialysis and Renal Disease Management
Canadian institutionsMcGill University
Fundersnot available
KeywordsMedicineBiostatisticsTownsendPediatricsPopulation healthFamily medicinePopulationEpidemiologyInternal medicine

Abstract

fetched live from OpenAlex

Background and Aims: Thiazide diuretics are recommended alone or in combination for uncomplicated hypertension (HTN). Most patients require treatment with 2 or more drugs. Based on studies of mono-therapy, ACE-I are recommended for patients at risk of renal disease, including diabetics. Data are sparse regarding thiazide plus ACE-I combination therapy. We hypothesized that thiazide plus ACE-I is associated with a lower incidence of renal disease compared with other common thiazide combinations, but that confounding by indication for diabetes might attenuate this effect. Methods: We conducted a retrospective cohort study of thiazide combinations in a 41-site clinical practice that is the dominant provider in a large rural area. Data were extracted from an electronic medical record for all patients >60 years treated for HTN between 2001 and 2006. Patients with prevalent renal disease, or <6 months of treatment or follow-up, were excluded. Diabetes was defined as ICD9 250.* Renal disease was defined as ICD-9 codes 403.*-404.*, 593.9, 585.*-586.* or an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2. Incident renal disease by eGFR required >2 measurements persisting >3 months. Results: Among 4700 patients (98% Caucasian, 69% female, mean age 70 yrs, mean follow-up 32.5 months), the incidence of renal disease was 22.7%. Five drug categories accounted for 97% of thiazide combinations: ACE-I, Angiotensin Receptor Blocker (ARB), Beta-blocker (BB), Calcium Channel Blocker (CCB) and Potassium-sparing diuretic (P-S). In Cox models with ACEI + thiazide as the reference group, adjusted for age, sex, and pretreatment blood pressure, patients who used BB + thiazide (HR 0.72, 95% CI, 0.600.86) and CCB + thiazide (HR 0.72, 0.55–0.96) had significantly lower hazard ratios for incident renal disease than those who used ACE-I + thiazide. In analyses stratified on diabetes status, results were generally similar for patients with and without diabetes except for the suggestion of a greater rate of incident renal disease in patients without diabetes who used P-S + thiazide (HR 1.23, 1.01–1.49) compared with ACE-I + thiazide. Conclusions: Contrary to expectation, ACE-I with thiazide was associated with an increased incidence of renal disease compared with all other groups except potassium-sparing diuretics. This risk was significantly greater than that observed with BB. The association was not meaningfully changed by accounting for diabetes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.021
Threshold uncertainty score0.042

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.158
GPT teacher head0.473
Teacher spread0.315 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2010
Admission routes1
Has abstractyes

Explore more

Same venueClinical Medicine & ResearchSame topicDialysis and Renal Disease ManagementFrench-language works237,207